Regenxbio resumed with an Outperform at Raymond James
Raymond James resumed coverage of Regenxbio (RGNX) with an Outperform rating and $27 price target The firm expects the launch of Elevidys and ...
Palantir or AMD: Raymond James Chooses the Better AI Stock to Buy After Earnings
January finished with an earthquake in the tech world, when the Chinese startup DeepSeek released its new AI assistant – and ...
Raymond James Financial Inc. stock outperforms competitors on strong trading day
This was the stock's second consecutive day of gains.
Apple supplier Skyworks stock plummets as iPhone maker turns to competitor
Apple supplier Skyworks Solutions saw its stock drop nearly 25% Thursday as the semiconductor firm said that it's losing ...
Lumen Technologies to Attend Investor Conferences
Chris Stansbury, executive vice president and chief financial officer at Lumen Technologies (NYSE: LUMN), will attend the following investor conferences: ...
Symbotic falls as Raymond James downgrades stock on disappointing earnings
Symbotic (NASDAQ:SYM) shares fell more than 17% in Thursday trade after Raymond James downgraded its rating from Outperform to Market Perform following a disappointing first quarter results. The ...
news.themarketisopen10h
Raymond James Delivers Strong Q1 Results, Embracing a Bright Future
Raymond James Financial, a leading financial services company, has announced its robust first-quarter performance for Fiscal ...
Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript
Operator Welcome to the Bristol Myers Squibb fourth quarter 2024 earnings conference call. [Operator instructions] Please note this event is being recorded. I would now like to turn the conference ...